Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00835978
What this trial is testing

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Pfizer 213
Early research (Phase 1)Study completedNCT01727076
What this trial is testing

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07470840
What this trial is testing

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Renal Cell Carcinoma
Fujian Cancer Hospital 27
Early research (Phase 1)Active Not RecruitingNCT06049576
What this trial is testing

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
City of Hope Medical Center 31
Very early researchNot Yet RecruitingNCT07671417
What this trial is testing

Imaging Study in Metastatic Clear Cell RCC.

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
RayzeBio, Inc. 10
Not applicableStudy completedNCT04941768
What this trial is testing

An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

Who this might be right for
Carcinoma, Renal Cell
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT03634540
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Who this might be right for
Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)Kidney Cancer+6 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 118
Testing effectiveness (Phase 2)Study completedNCT00080795
What this trial is testing

Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
M.D. Anderson Cancer Center 65
Not applicableStudy completedNCT00718367
What this trial is testing

Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens

Who this might be right for
Renal Cell Carcinoma
National University Hospital, Singapore
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07630363
What this trial is testing

PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

Who this might be right for
Advanced Renal Cell Carcinoma (RCC)PTCAtorvastatin+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Early research (Phase 1)Study completedNCT01625936
What this trial is testing

CRLX101 Plus Bevacizumab in Advanced RCC

Who this might be right for
Renal Cell Carcinoma
Abramson Cancer Center at Penn Medicine 22
Testing effectiveness (Phase 2)Ended earlyNCT01793636
What this trial is testing

A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Carcinoma
Queen Mary University of London 49
Testing effectiveness (Phase 2)Study completedNCT07568444
What this trial is testing

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

Who this might be right for
Prostate Cancer (Adenocarcinoma)Bladder CancerKidney Cancers+1 more
University of Southern California 120
Testing effectiveness (Phase 2)Study completedNCT00009867
What this trial is testing

Arsenic Trioxide in Treating Patients With Urothelial Cancer

Who this might be right for
Recurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerTransitional Cell Carcinoma of the Bladder+1 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00021021
What this trial is testing

RPI.4610 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Ribozyome
Not applicableWithdrawnNCT04680416
What this trial is testing

Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors

Who this might be right for
Renal Clear Cell Carcinoma
TScan Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT00661375
What this trial is testing

BAY43-9006 Phase II Study for Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 131
Testing effectiveness (Phase 2)Looking for participantsNCT07226544
What this trial is testing

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Who this might be right for
Localized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03355976
What this trial is testing

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+2 more
Brown University 46
Testing effectiveness (Phase 2)UnknownNCT06222125
What this trial is testing

HB0025 Injection in Patients With Advanced Renal Cancer

Who this might be right for
Renal Cancer
Huabo Biopharm Co., Ltd. 100
Next Page